Ann Gidner

Company: Ziccum AB

Job title: Chief Executive Officer

Seminars:

From mRNA Concept to Viable Drug Project – Unlocking the Full Potential of mRNA 11:45 am

Reduce drug cost dramatically with thermostable, robust dry product forms thanks to unique technology based on solid IP Preserve or even increase mRNA activity with technology proven in-vitro and in-vivo Enable dry powder inhalation of mRNA/LNP thanks to sophisticated particle engineeringRead more

day: Day 1 Track 2 AM